CABTREO: Topical Acne Treatment (Not an Osteoporosis Medication)
CABTREO is a topical gel containing clindamycin phosphate 1.2%, adapalene 0.15%, and benzoyl peroxide 3.1% used exclusively for treating acne vulgaris on the skin—it has no relationship to osteoporosis treatment or bone health. 1
What CABTREO Is
CABTREO is a prescription topical medication combining three active ingredients for acne treatment:
- Clindamycin phosphate (antibiotic)
- Adapalene (retinoid)
- Benzoyl peroxide (antimicrobial/keratolytic)
This appears to be a case of confusion with similarly-named medications. You may be thinking of combination products containing alendronate (a bisphosphonate) with vitamin D3 for osteoporosis treatment, which have entirely different names and formulations.
How to Use CABTREO (For Acne Only)
Application Instructions:
- Apply once daily to affected areas after cleansing and drying the skin 1
- Dispense one pea-sized amount from the pump
- Dot onto six areas of the face (chin, both cheeks, nose, both sides of forehead) 1
- Spread gently over the entire face
- Wash hands after application
Critical Warnings:
- For topical use only—not for oral, ophthalmic, or intravaginal use 1
- Avoid eyes, mouth, mucous membranes, and broken/eczematous/sunburned skin 1
- Store at room temperature ≤77°F (25°C), keep upright, away from heat 1
If You're Looking for Osteoporosis Treatment
For postmenopausal osteoporosis, first-line treatment is oral bisphosphonates (alendronate or risedronate) combined with adequate calcium (1000-1200 mg daily) and vitamin D3 (800-1000 IU daily). 2
Combination products containing alendronate 70 mg with cholecalciferol (vitamin D3) 2800 IU are available as once-weekly tablets for osteoporosis treatment 3, 4. These provide proven fracture reduction at vertebral, non-vertebral, and hip sites 2.
Key osteoporosis treatment principles:
- Alendronate, risedronate, zoledronic acid, or denosumab reduce hip and vertebral fractures in women with known osteoporosis 2
- Treatment duration should be 5 years initially 2
- Vitamin D supplementation (800-1000 IU daily) is essential for all patients on bone-protective therapy 5
- Adequate calcium intake (1000-1200 mg daily through diet or supplements) is required 5
CABTREO has no role in bone health or osteoporosis management whatsoever.